Abstract
Portal hypertension is associated with a wide range of pulmonary pathophysiologies, ranging from portopulmonary hypertension to hepatopulmonary syndrome. Although the clinical and pathological features of pulmonary dysfunction in this setting have been extensively characterized, the underlying biology is not well understood. Specifically, the role of mediators that regulate mesenteric vascular hemodynamics in portal hypertension, such as nitric oxide and endothelin, have not been studied in the lung. Using a rat model of prehepatic portal hypertension with preserved hepatic function, we examined pulmonary elaboration of endothelial nitric oxide synthase (NOS), inducible NOS, heme oxygenase- 1 (HO-1), heme oxygenase-2 (HO-2), endothelin-1 mRNA, and protein. In comparison to sham controls, portal hypertensive animals exhibited significantly increased pulmonary iNOS and HO-1 mRNA and protein. Cyclic GMP was significantly increased in portal hypertensive lung tissue, suggesting activation of guanylyl cyclase by the endproducts of iNOS and/or HO-1 activity. Using immunohistochemical analysis, iNOS expression was localized to the vascular endothelium, while HO-1 localized to bronchiolar epithelium and macrophages. These results suggest that production of nitric oxide and carbon monoxide may contribute to the pulmonary pathology associated with portal hypertension.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
REFERENCES
Lamps LW, Carson K, Bradley AL, Pinson CW, Johnson JE, Coogan AC, Hunter EB, Clavien PA, Washington MK: Pulmonary vascular morphological changes in cirrhotic patients undergoing liver transplantation. Liver Trans Surg 5:57-64, 1999
Kuo PC, Plotkin JS, Johnson LB, Howell CD, Laurin JM, Bartlett ST, Rubin LJ: Distinctive clinical features of portopulmonary hypertension. Chest 112:980-986, 1998
Luo B, Abrams GA, Fallon MB: Endothelin-1 in the rat bile duct ligation model of hepatopulmonary syndrome: Correlation with pulmonary dysfunction. J Hepatol 29:571-578, 1998
Behera D, Singh M, Chawla Y, Dilawari JB: Pulmonary function abnormality in patients with portal hypertension with or without chronic liver disease. Indian J Chest Dis Allied Sci 40:33-39, 1998
Cahill PA, Hou MC, Hendirckson R, Wang YN, Zhang S, Redmond EM, Sitzmann JV: increased expression of endothelin receptors in the vaculature of portal hypertensive rats: Role in splanchnic hemodynamics. Hepatology 28:396-403, 1998
Cahill PA, Foster C, Redmond EM, Gingalewski C, Wu Y, Sitzmann JV: Enhanced nitric oxide synthase activity in portal hypertensive rabbits. Hepatology 22:598-606, 1995
Kuo PC, Slivka A: Nitric oxide decreases oxidant mediated hepatocyte injury. J Surg Res 56:594-600, 1994
Kuo PC, Abe KY, Schroeder RA. Interleukin-1 induced nitric oxide production modulates glutathione synthesis in cultured rat hepatocytes. Am J Physiol 217:C851-C862, 1996
Lasota J, Jasinki M, Sarlomo-Rikala M, Miettinen M: Mutations in exon 11 of c-kit occur preferentially in malignant versus benign gastrointestinal stromal tumors and do not occur in leiomyomas or leiomyosarcomas. Am J Pathol 154:53-60, 1999
Wiest R, Shah V, Sessa WC, Groszmann RJ: NO over production by eNOS precedes hyperdynamic splanchnic circulation in portal hypertensive rats. Am J Physiol 276:G1043-G1051, 1999
Cahill PA, Redmond EM, Hodges R, Zhang S, Sitzmann JV: Increased endothelial nitric oxide synthase activity in the hyperemic vessels of portal hypertensive rats. J Hepatol 25:370-378, 1996
Niderberger M, Gines P, Martin PY, Tsai P, Morris K, Mc-Murtry I, Schrier RW: Comparison of vascular nitric oxide production and systemic hemodynamics in cirrhosis versus portal hypertension in rats. Hepatology 24:947-951, 1996
Gadano AC, Sogni P, Heller J, Moreau R, Bories PN, Lebrec D: Vascular nitric oxide production during the development of two experimental models of portal hypertension. J Hepatol 30:896-903, 1999
Martin PD, Xu D, Niderberger M, Weigert P, Gines P, Schrier R: Upregulation of endothelial constitutive NOS: a major role in the increased NO production in cirrhotic rats. Am J Physiol 270:F494-F499, 1996
Zhang M, Luo B, Chen SJ, Abrams GA, Fallon MB: Endothelin-1 stimulation of endothelial nitric oxide synthase in the pathogenesis of hepatopulmonary syndrome. Am J Physiol 277:G944-G952, 1999
Fernandez M, Bonkovsky HL: Increased heme-oxygenase-1 gene expression in liver cells and splanchnic organs from portal hypertensive rats. Hepatology 29:1672-1679, 1999
Camhi SL, Alam J, Otterbein L, Sylvester SL, Choi AM: Induction of heme oxygenase-1 gene expression by lipopolysaccharide is mediated by AP-1 activation. Am J Respir Cell Mol Biol 13:387-398, 1995
Carraway MS, Ghio AJ, Taylor JL, Piantadosi CA: Induction of ferritin and heme oxygenase-1 by endotoxin in the the lung. Am J Physiol 275:L583-L592, 1998
Lee PJ, Alam J, Sylvester SL, Inamdar N, Otterbein L, Choi AM: Regulation of heme oxygenase-1 expression in vivo and in vitro in hyperoxic lung injury. Am J Respir Cell Mol Biol 14:556-598, 1996
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Schroeder, R.A., Ewing, C.A., Sitzmann, J.V. et al. Pulmonary Expression of iNOS and HO-1 Protein Is Upregulated in a Rat Model of Prehepatic Portal Hypertension. Dig Dis Sci 45, 2405–2410 (2000). https://doi.org/10.1023/A:1005651327654
Issue Date:
DOI: https://doi.org/10.1023/A:1005651327654